PhD
Associate Professor, Pathology and Laboratory Medicine
UNC-Chapel Hill
Cancer Genetics Research Program
Area of Interest
The lab of Jeremy Wang, PhD, applies high-performance computational methods and novel high-throughput sequencing approaches to advance precision personalized medicine with a focus on molecular diagnostics in cancer and infectious diseases.
The lab broadly aims to develop, validate, and implement nanopore sequencing-based molecular diagnostic tools enabling comprehensive genomic characterization of pediatric and adult cancers.
Current work focuses on using low-cost nanopore RNA- and DNA-sequencing to enable comprehensive molecular characterization of pediatric acute leukemias and solid tumors in low-resource settings where traditional diagnostic infrastructure is unavailable.
Making a meaningful contribution to personalized medicine requires highly collaborative multidisciplinary science. As such, the lab works closely with clinical, translational, basic science, and computational collaborators at UNC and around the world.
News and Stories
UNC researchers develop faster, low-cost method to diagnose common pediatric cancer
Jeremy R. Wang, PhD, and colleagues have created a new way for oncologists to more sensitively detect genetic mutations in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer.
Adaptive whole-genome sequencing could transform childhood leukemia diagnosis
UNC Lineberger researchers have demonstrated a faster, more cost-effective approach to analyzing the genetic makeup of pediatric acute leukemia. Determining a cancer’s genomic classification is critical to developing a more effective treatment plan tailored to a patient’s tumor.
